Digital Twin in Oncology Market Size, Share, and Trends 2026 to 2035

Digital Twin in Oncology Market (By Component: Software Platform,s Services; By Type: Patient Digital Twin, Process/Workflow, Device/Equipment Twin, Whole Body/System Twin; By Application: Drug Discovery & Clinical Trails, Surgical Planning & Simulation, Hospital & Asset Management; By End User: Pharmaceutical & Biotech Companies, Research & Academic Institutes) - Global Industry Analysis, Size, Trends, Leading Companies, Regional Outlook, and Forecast 2026 to 2035

Last Updated : 13 Feb 2026  |  Report Code : 7707  |  Category : Healthcare   |  Format : PDF / PPT / Excel

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Digital Twin in Oncology Market 

5.1. COVID-19 Landscape: Digital Twin in Oncology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Digital Twin in Oncology Market, By Component

8.1. Digital Twin in Oncology Market, by Component

8.1.1. Software Platforms

8.1.1.1. Market Revenue and Forecast

8.1.2. Services

8.1.2.1. Market Revenue and Forecast

Chapter 9. Global Digital Twin in Oncology Market, By Type

9.1. Digital Twin in Oncology Market, by Type

9.1.1. Patient Digital Twin

9.1.1.1. Market Revenue and Forecast

9.1.2. Process/Workflow

9.1.2.1. Market Revenue and Forecast

9.1.3. Device/Equipment Twin

9.1.3.1. Market Revenue and Forecast

9.1.4. Whole Body/System Twin

9.1.4.1. Market Revenue and Forecast  

Chapter 10. Global Digital Twin in Oncology Market, By Application

10.1. Digital Twin in Oncology Market, by Application

10.1.1. Drug Discovery & Clinical Trails

10.1.1.1. Market Revenue and Forecast

10.1.2. Surgical Planning & Simulation

10.1.2.1. Market Revenue and Forecast

10.1.3. Hospital & Asset Management

10.1.3.1. Market Revenue and Forecast

Chapter 11. Global Digital Twin in Oncology Market, By End User

11.1. Digital Twin in Oncology Market, by End User

11.1.1. Pharmaceutical & Biotech Companies

11.1.1.1. Market Revenue and Forecast

11.1.2. Research & Academic Institutes

11.1.2.1. Market Revenue and Forecast

Chapter 12. Global Digital Twin in Oncology Market, Regional Estimates and Trend Forecast

12.1. North America

12.1.1. Market Revenue and Forecast, by Component

12.1.2. Market Revenue and Forecast, by Type

12.1.3. Market Revenue and Forecast, by Application

12.1.4. Market Revenue and Forecast, by End User

12.1.5. U.S.

12.1.5.1. Market Revenue and Forecast, by Component

12.1.5.2. Market Revenue and Forecast, by Type

12.1.5.3. Market Revenue and Forecast, by Application

12.1.5.4. Market Revenue and Forecast, by End User

12.1.6. Rest of North America

12.1.6.1. Market Revenue and Forecast, by Component

12.1.6.2. Market Revenue and Forecast, by Type

12.1.6.3. Market Revenue and Forecast, by Application

12.1.6.4. Market Revenue and Forecast, by End User

12.2. Europe

12.2.1. Market Revenue and Forecast, by Component

12.2.2. Market Revenue and Forecast, by Type

12.2.3. Market Revenue and Forecast, by Application

12.2.4. Market Revenue and Forecast, by End User

12.2.5. UK

12.2.5.1. Market Revenue and Forecast, by Component

12.2.5.2. Market Revenue and Forecast, by Type

12.2.5.3. Market Revenue and Forecast, by Application

12.2.5.4. Market Revenue and Forecast, by End User

12.2.6. Germany

12.2.6.1. Market Revenue and Forecast, by Component

12.2.6.2. Market Revenue and Forecast, by Type

12.2.6.3. Market Revenue and Forecast, by Application

12.2.6.4. Market Revenue and Forecast, by End User

12.2.7. France

12.2.7.1. Market Revenue and Forecast, by Component

12.2.7.2. Market Revenue and Forecast, by Type

12.2.7.3. Market Revenue and Forecast, by Application

12.2.7.4. Market Revenue and Forecast, by End User

12.2.8. Rest of Europe

12.2.8.1. Market Revenue and Forecast, by Component

12.2.8.2. Market Revenue and Forecast, by Type

12.2.8.3. Market Revenue and Forecast, by Application

12.2.8.4. Market Revenue and Forecast, by End User

12.3. APAC

12.3.1. Market Revenue and Forecast, by Component

12.3.2. Market Revenue and Forecast, by Type

12.3.3. Market Revenue and Forecast, by Application

12.3.4. Market Revenue and Forecast, by End User

12.3.5. India

12.3.5.1. Market Revenue and Forecast, by Component

12.3.5.2. Market Revenue and Forecast, by Type

12.3.5.3. Market Revenue and Forecast, by Application

12.3.5.4. Market Revenue and Forecast, by End User

12.3.6. China

12.3.6.1. Market Revenue and Forecast, by Component

12.3.6.2. Market Revenue and Forecast, by Type

12.3.6.3. Market Revenue and Forecast, by Application

12.3.6.4. Market Revenue and Forecast, by End User

12.3.7. Japan

12.3.7.1. Market Revenue and Forecast, by Component

12.3.7.2. Market Revenue and Forecast, by Type

12.3.7.3. Market Revenue and Forecast, by Application

12.3.7.4. Market Revenue and Forecast, by End User

12.3.8. Rest of APAC

12.3.8.1. Market Revenue and Forecast, by Component

12.3.8.2. Market Revenue and Forecast, by Type

12.3.8.3. Market Revenue and Forecast, by Application

12.3.8.4. Market Revenue and Forecast, by End User

12.4. MEA

12.4.1. Market Revenue and Forecast, by Component

12.4.2. Market Revenue and Forecast, by Type

12.4.3. Market Revenue and Forecast, by Application

12.4.4. Market Revenue and Forecast, by End User

12.4.5. GCC

12.4.5.1. Market Revenue and Forecast, by Component

12.4.5.2. Market Revenue and Forecast, by Type

12.4.5.3. Market Revenue and Forecast, by Application

12.4.5.4. Market Revenue and Forecast, by End User

12.4.6. North Africa

12.4.6.1. Market Revenue and Forecast, by Component

12.4.6.2. Market Revenue and Forecast, by Type

12.4.6.3. Market Revenue and Forecast, by Application

12.4.6.4. Market Revenue and Forecast, by End User

12.4.7. South Africa

12.4.7.1. Market Revenue and Forecast, by Component

12.4.7.2. Market Revenue and Forecast, by Type

12.4.7.3. Market Revenue and Forecast, by Application

12.4.7.4. Market Revenue and Forecast, by End User

12.4.8. Rest of MEA

12.4.8.1. Market Revenue and Forecast, by Component

12.4.8.2. Market Revenue and Forecast, by Type

12.4.8.3. Market Revenue and Forecast, by Application

12.4.8.4. Market Revenue and Forecast, by End User

12.5. Latin America

12.5.1. Market Revenue and Forecast, by Component

12.5.2. Market Revenue and Forecast, by Type

12.5.3. Market Revenue and Forecast, by Application

12.5.4. Market Revenue and Forecast, by End User

12.5.5. Brazil

12.5.5.1. Market Revenue and Forecast, by Component

12.5.5.2. Market Revenue and Forecast, by Type

12.5.5.3. Market Revenue and Forecast, by Application

12.5.5.4. Market Revenue and Forecast, by End User

12.5.6. Rest of LATAM

12.5.6.1. Market Revenue and Forecast, by Component

12.5.6.2. Market Revenue and Forecast, by Type

12.5.6.3. Market Revenue and Forecast, by Application

12.5.6.4. Market Revenue and Forecast, by End User

Chapter 13. Company Profiles

13.1. Dassault Systems (3DEXPERIENCE)

13.1.1. Company Overview

13.1.2. Product Offerings

13.1.3. Financial Performance

13.1.4. Recent Initiatives

13.2. Siemens Healthineers AG

13.2.1. Company Overview

13.2.2. Product Offerings

13.2.3. Financial Performance

13.2.4. Recent Initiatives

13.3. Microsoft Corporation (Azure Digital Twins)

13.3.1. Company Overview

13.3.2. Product Offerings

13.3.3. Financial Performance

13.3.4. Recent Initiatives

13.4. IBM Corporation (Watson Health/Life Sciences)

13.4.1. Company Overview

13.4.2. Product Offerings

13.4.3. Financial Performance

13.4.4. Recent Initiatives

13.5. GE HealthCare

13.5.1. Company Overview

13.5.2. Product Offerings

13.5.3. Financial Performance

13.5.4. Recent Initiatives

13.6. Ansys, Inc.

13.6.1. Company Overview

13.6.2. Product Offerings

13.6.3. Financial Performance

13.6.4. Recent Initiatives

13.7. Unlearn.AI, Inc.

13.7.1. Company Overview

13.7.2. Product Offerings

13.7.3. Financial Performance

13.7.4. Recent Initiatives

13.8. Twin Health

13.8.1. Company Overview

13.8.2. Product Offerings

13.8.3. Financial Performance

13.8.4. Recent Initiatives

13.9. Philips Healthcare

13.9.1. Company Overview

13.9.2. Product Offerings

13.9.3. Financial Performance

13.9.4. Recent Initiatives

13.10. Aitia (formerly GNS Healthcare)

13.10.1. Company Overview

13.10.2. Product Offerings

13.10.3. Financial Performance

13.10.4. Recent Initiatives

Chapter 14. Research Methodology

14.1. Primary Research

14.2. Secondary Research

14.3. Assumptions

Chapter 15. Appendix

15.1. About Us

15.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

Answer : The digital twin in oncology market size is expected to increase from USD 450.00 million in 2025 to USD 7226.90 million by 2035.

Answer : The digital twin in oncology market is expected to grow at a compound annual growth rate (CAGR) of around 32.00% from 2026 to 2035.

Answer : The driving factors of the digital twin in oncology market are the increasing shift toward personalized oncology care, the use of digital twins in clinical trials and drug development, and advancements in real-time tumor simulation and monitoring to improve treatment outcomes.

Answer : North America region will lead the global digital twin in oncology market during the forecast period 2026 to 2035.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client